74
Participants
Start Date
July 31, 2009
Primary Completion Date
May 31, 2010
Study Completion Date
January 31, 2011
ribavirin
Ribavirin - oral administration Subjects with body weight \< 65 kg: 800 mg/day Subjects with body weight 65-85 kg: 1000 mg/day Subjects with body weight 86-105 kg: 1200 mg/day Subjects with body weight \> 105 kg: 1400 mg/day
Tokuda Hospital, Sofia
"UMHAT Alexandrovska", Sofia
"UMHAT St Ivan Rilski", Sofia
"UMHAT Queen Giovanna - ISUL EAD", Sofia
Medical Institute Ministry of Interior, Sofia
"UMHAT St Maria", Varna
Rebekah Ziv Medical Center Safed, Safed
Holy Family Hospital Nazareth, Nazareth
Carmel Medical Center, Haifa
Rabin Medical Center, Petah Tikva
Sourasky Medical Center, Tel Aviv
"Victor Babes Clinical Hospital Craiova", Craiova
Gastroenterology and Hepatology Institute, Iași
Institute of Infectious Diseases, Bucharest
Fundeni Clinical Institute, Bucharest
Lead Sponsor
Biolex Therapeutics, Inc.
INDUSTRY